ARCHIVES

University of Oklahoma Wins Planning Grant; Three Mile Island Follow-Up Finds No Significant Increase In Cancer Deaths

This article is from The Cancer Letter archive.

Vol. 28 No. 40 | November 2, 2002

Download PDF Visit The Full Archive

Related Articles

Is $45 Million Too Much to Spend on PR? NCAB Panel Weighs NCI Communications Budget

December 7, 2012

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007

White House Announces FDA Initiatives To accelerate Cancer Drug Approval

April 4, 1996

Raymond Weiss Reviews Confidential Report on I-ELCAP

April 29, 2011

Gleevec Improves Survival Of CML In Accelerated Phase

December 27, 2002

US Oncology Clarifies Role of Pharmacy Committee

January 24, 2003